Alzamend Neuro, Inc. announced plans to start a phase II clinical study of AL001, focusing on its use for patients with bipolar disorder (BD), set to begin in the third quarter of 2025.
6d
News-Medical.Net on MSNNext-generation, inhaled COVID-19 vaccine enters phase-2 clinical trialResearchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
2h
MyChesCo on MSNFaeth Therapeutics and GOG Foundation Launch Pioneering Phase 2 Trial for Advanced Endometrial CancerAUSTIN, TX & PHILADELPHIA, PA — Faeth Therapeutics and The GOG Foundation, Inc. have announced a significant milestone in the ...
has completed the enrollment in the Phase 2 clinical study of DR10624 for the treatment of severe hypertriglyceridemia (SHTG) ("DR10624-201 study"). The DR10624-201 study is a randomized ...
Receiving the FDA’s clearance to proceed with our Phase 2 clinical trial for TPST-1495, our second clinical program, in FAP marks an important step forward in developing new treatment options for ...
We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...
BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology ... decision to temporarily pause the Phase 2 CONNECT2-EDO51 study of PGN-EDO51 in patients with Duchenne ...
The interim results highlight strong potential, paving the way for further clinical advancement. Key interim findings include: Efficacy: Bimiralisib topical gel (2 ... study toward the next phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results